Is the functional interaction between adenosine A(2A) receptors and metabotropic glutamate 5 receptors a general mechanism in the brain? Differences and similarities between the striatum and the hippocampus.

Purinergic Signalling
Maria Teresa TebanoPatrizia Popoli

Abstract

The aim of the present paper was to examine, in a comparative way, the occurrence and the mechanisms of the interactions between adenosine A(2A) receptors (A(2A)Rs) and metabotropic glutamate 5 receptors (mGlu5Rs) in the hippocampus and the striatum. In rat hippocampal and corticostriatal slices, combined ineffective doses of the mGlu5R agonist 2-chloro-5-hydroxyphenylglycine (CHPG) and the A(2A)R agonist CGS 21680 synergistically reduced the slope of excitatory postsynaptic field potentials (fEPSPs) recorded in CA1 and the amplitude of field potentials (FPs) recorded in the dorsomedial striatum. The cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathway appeared to be involved in the effects of CGS 21680 in corticostriatal but not in hippocampal slices. In both areas, a postsynaptic locus of interaction appeared more likely. N-methyl-D: -aspartate (NMDA) reduced the fEPSP slope and FP amplitude in hippocampal and corticostriatal slices, respectively. Such an effect was significantly potentiated by CHPG in both areas. Interestingly, the A(2A)R antagonist ZM 241385 significantly reduced the NMDA-potentiating effect of CHPG. In primary cultures of rat hippocampal and striatal neurons (ED 17, DIV 14), CHPG significan...Continue Reading

References

May 8, 1995·The Journal of Comparative Neurology·C RomanoJ W Olney
Apr 3, 1995·The Journal of Comparative Neurology·C M TestaA B Young
Dec 12, 1995·European Journal of Pharmacology·P PopoliG Ricciarello
Feb 12, 1999·Brain Research. Brain Research Reviews·R Anwyl
Sep 6, 2000·Trends in Pharmacological Sciences·A M Sebastião, J A Ribeiro
May 30, 2001·Neuropharmacology·P GubelliniP Calabresi
Aug 29, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·V BrunoF Nicoletti
Aug 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sergi FerréFrancisco Ciruela
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Akinori NishiPaul Greengard
Feb 7, 2003·Current Topics in Medicinal Chemistry·Bertil B FredholmPer Svenningsson
Mar 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Roberto CoccurelloMarianne Amalric
Dec 8, 2004·Critical Reviews in Neurobiology·Patrizia PopoliMarino Massotti
Nov 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anil KachrooMichael A Schwarzschild

❮ Previous
Next ❯

Citations

Mar 28, 2008·Purinergic Signalling·I Novak
Apr 18, 2018·Current Neuropharmacology·David Agustín León-NavarroMairena Martín

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.